Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association
Connie W. Tsao et al.
CIRCULATION (2022)
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study
Jose R. Gonzalez-Juanatey et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph et al.
LANCET (2021)
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K. Ray et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Regulation of Cardiovascular Therapies During the COVID-19 Public Health Emergency
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Hmwe Hmwe Kyu et al.
LANCET (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8
Sun Jae Moon et al.
PLOS ONE (2017)
The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention
Kornelia Kotseva
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes
Sameer Bansilal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk
Anushka Patel et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Evolution of the Polypill Concept and Ongoing Clinical Trials
Jose M. Castellano et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Non-adherence to cardiovascular medications
Kumaran Kolandaivelu et al.
EUROPEAN HEART JOURNAL (2014)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
WHAT SHOULD WE DIE FROM? Cardiovascular disease and cancer compete for the outcome of death
Greg Irving
BMJ-BRITISH MEDICAL JOURNAL (2014)
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
Vanessa Selak et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis
Daniel Caldeira et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2014)
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Rajiv Chowdhury et al.
EUROPEAN HEART JOURNAL (2013)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence
Kumaran Kolandaivelu et al.
NATURE REVIEWS CARDIOLOGY (2010)
Are There Effects of Renin–Angiotensin System Antagonists Beyond Blood Pressure Control?
George Bakris
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Share Paper
